Copyright
        ©The Author(s) 2018.
    
    
        World J Stem Cells. Nov 26, 2018; 10(11): 172-182
Published online Nov 26, 2018. doi: 10.4252/wjsc.v10.i11.172
Published online Nov 26, 2018. doi: 10.4252/wjsc.v10.i11.172
		Figure 1 Mechanism of action of different non-cancer related drugs against pancreatic cancer stem cells.
		
			 EMT: Epithelial mesenchymal transition; ALDH1: Aldehyde dehydrogenase 1; NF-κB: Nuclear factor kappa-light-chain-enhancer of activated B cells; mTOR: Mammalian target of rapamycin; PI3K: Phosphatidylinositol 3-kinase; Akt: Protein kinase B; OXPHOS: Oxidative phosphorylation.
		
	
		Figure 2 The types of nanoparticles.
		
			 A: Different types of nanoparticles for targeted drug delivery; B: Specific nanoparticles for targeting pancreatic cancer stem cells. PCSCs: Pancreatic cancer stem cells.
		
	
- Citation: Di Carlo C, Brandi J, Cecconi D. Pancreatic cancer stem cells: Perspectives on potential therapeutic approaches of pancreatic ductal adenocarcinoma. World J Stem Cells 2018; 10(11): 172-182
- URL: https://www.wjgnet.com/1948-0210/full/v10/i11/172.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v10.i11.172

 
         
                         
                 
                 
                 
                 
                 
                         
                         
                         
                         
			